About
Dr. Viegas received his B.S. in Chemistry (1977) and Pharmacy (1981) from Bangalore University, his M.S. (1984) and Ph.D. (1988) in Pharmaceutical Sciences from the University of Mississippi. He worked at R.P. Scherer Corporation (now Catalent), MDV Technologies, BioCryst Pharmaceuticals and Shearwater Corporation (now Nektar Therapeutics). He has 22 years of pharmaceutical industrial experience in drug discovery, drug delivery and pharmacokinetics. Dr. Viegas has managed the discovery and early development activities for both synthetically- and biologically-derived therapeutic agents in the areas of oncology, pain, influenza, psoriasis and wound care. He has numerous patents and publications in the area of polymer therapeutics and pharmaceutics, and he also received the American College of Clinical Pharmacology award for his presentation on the clinical applications of purine nucleosides.
Position in the VCSift Database
- • 2 investors at Serina Therapeutics are tracked.
- • 76 investors hold the Chief Operating Officer role in VCSift. Tacey Viegas is one of them.
- • 28 investors are based in Huntsville, Alabama, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Huntsville, US
Contact Information
Find more investors like Tacey
Search Investors